🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Clinical and Radiographic Outcomes After AMIC Treatment for Talus Osteochondral Lesion Trattamento Artroscopico Delle Lesioni Osteocondrali Dell'Astragalo Con Tecnica AMIC

RecruitingNAAges 18 Years - 65 YearsAllI.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio
NCT03371121 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

Aim of the study is to evaluate clinical and radiographic outcomes in patients undergone all-arthroscopic autologous matrix induced chondrogenesis for symptomatic osteochondral talar lesions

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Age over 18 years * males and females * patients underwent arthroscopic cartilage reconstruction surgery with AMIC technique for osteochondral lesions of the talus Exclusion Criteria: * age \<18 years at the time of surgery * patients with previous surgery on the affected ankle
💊

What it tests

  • AT-AMIC (arthroscopic talus autologous matrix induced chondrogenesis)
📍

Where

1 site
Federico Usuelli
Milan, Italy
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy